Anal Intraepithelial Neoplasia Treatment in Nepal AIN/HSIL — the HPV-Driven Anal Precancer, Detected + Ablated Early
Specialist management of anal intraepithelial neoplasia (AIN/HSIL) — the HPV-driven precancer that, untreated, progresses to anal cancer. High-resolution anoscopy, ablation, and surveillance at Thamel Clinic.
Medically Reviewed Content
Reviewed by: STD Specialist (MBBS, MD - Medicine)
NMC Registration:
Last medical review: June 1, 2026
This content follows evidence-based medical guidelines and is regularly updated to reflect current medical practices.
AIN in Nepal
- Under-screened — anal precancer screening is uncommon in Nepal; high-risk groups benefit most.
- HPV-16 driven — the same pathway as cervical cancer; the risk groups are known.
- HIV-associated — people with HIV have substantially increased AIN/anal-cancer risk; they benefit most from screening.
- HRA-guided — high-resolution anoscopy is the standard diagnostic; we coordinate it.
Anal Intraepithelial Neoplasia — the Precancer
Anal intraepithelial neoplasia (AIN) — the anal equivalent of cervical dysplasia — is **HPV-driven precancer** of the anal canal and perianal skin. Graded AIN 1/2/3, with AIN 2-3 (HSIL) being the significant precancer that progresses to anal cancer if untreated.
It's increased in people who have receptive anal sex, people with HIV/immunosuppression, smokers, and those with genital HPV disease — and it's frequently asymptomatic or presents as non-specific perianal itch/lesions.
High-grade AIN is **treatable and preventable** — detection + ablation dramatically reduces progression. This page explains it.
Who Benefits from Screening
Receptive anal sex
People who have receptive anal intercourse — the key risk factor.
HIV / immunosuppression
Substantially increased risk — the group who benefit most from screening.
Genital HPV/warts
Existing genital HPV disease indicates the pathway is present.
Smoking + others
Smoking and other immunosuppression add risk.
Diagnosis — HRA + Biopsy
**High-resolution anoscopy (HRA)** is the standard diagnostic — a magnified examination of the anal canal with acetic acid and Lugol's, identifying lesions that are then **biopsied**.
Biopsy confirms the grade (AIN 1 = LSIL, AIN 2-3 = HSIL) and excludes invasion — the grade determines the surveillance/treatment pathway.
Treatment — Preventing Cancer
Ablation
HRA-guided targeted ablation (electrocautery, laser, infrared) — the standard for high-grade AIN; prevents progression.
Topical therapy
Imiquimod or 5-fluorouracil for selected lesions — medical management option.
Excision
Surgical excision of focal high-grade or suspicious lesions — provides histology.
Surveillance
Ongoing HRA + cytology follow-up — recurrence is common; the surveillance catches it.
The Underlying Pathway
AIN is the anal expression of the HPV-driven pathway — managing it means more than the individual lesions: HIV assessment, partner counselling, HPV vaccination discussion, cervical screening in women, and smoking cessation.
We coordinate the whole pathway — the goal is preventing the anal cancer, not just treating the lesions.
AIN Care & Costs
| Service | What It Includes | Cost (NPR) |
|---|---|---|
| Specialist consultation | Risk assessment + examination | Rs. 450 |
| HRA + biopsy coordination | Confirms grade + excludes invasion | Coordinated |
| Ablation/topical/excision | Treats high-grade AIN | Per case |
| HPV pathway + surveillance | Wider risk + follow-up | Coordinated |
Transparent pricing; confirm current rates on booking.
Why Thamel Clinic for AIN
- High-risk screening — we identify and screen the people who benefit most.
- HRA-guided biopsy — the correct diagnostic pathway.
- Cancer prevention — ablation prevents progression to anal cancer.
- HPV pathway managed — the underlying risk addressed.
- Confidential — discreet, non-judgmental, specialist.
Frequently Asked Questions
What is AIN?
Anal intraepithelial neoplasia — the HPV-driven precancer of the anal canal. High-grade AIN (HSIL) is the precancer that, untreated, can progress to anal cancer — treated here it's largely prevented.
Who should be screened?
People who have receptive anal sex, people with HIV/immunosuppression, smokers, and those with genital HPV/warts — the higher-risk groups benefit most.
Is it curable?
Yes — high-grade AIN is treatable with ablation/topical/excision. The treatment prevents progression to cancer; surveillance catches recurrence.
Is it related to cervical HPV?
Yes — the same HPV-16 pathway drives both. Partners and cervical screening in women are part of the management.
Still have questions? Contact us or book an appointment for personalized guidance.
Related Services & Guides
Related Health Guides
Medical Disclaimer
Important information about using this medical website
Educational Purpose Only
The information provided on this website, including all text, graphics, images, and other material, is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
No Doctor-Patient Relationship
Use of this website does not create a doctor-patient relationship. The information provided is not tailored to your specific medical condition or health needs. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Emergency Situations
If you think you may have a medical emergency, call your doctor or emergency services immediately. In Nepal, call 102 for emergency services or go to the nearest hospital emergency room.
Emergency Contact Information:
National Emergency:
102 (Ambulance)
Our Clinic:
+977-9700682800 (WhatsApp available 24/7)
Bir Hospital Emergency:
+977-1-4412400
TU Teaching Hospital:
+977-1-4434320
Timeliness of Information
Medical information changes rapidly. While we strive to provide current and accurate information, we make no guarantees about the completeness, accuracy, reliability, suitability, or availability with respect to the website or the information contained on the website.
Professional Medical Advice Required
Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you have any specific questions about any medical matter, you should consult your doctor or other professional healthcare provider.
Treatment and Diagnosis
Do not use the information on this website to diagnose or treat any health problem or disease. The descriptions of treatments and medications provided are for general informational purposes only and do not constitute medical advice.
Limitation of Liability
In no event shall we be liable for any loss or damage arising from the use of this website or reliance on the information provided herein. This includes, but is not limited to, direct, indirect, incidental, punitive, and consequential damages.
Nepal-Specific Considerations
This website is operated in Nepal and is intended for users in Nepal. The medical information provided may not be applicable to healthcare systems outside Nepal. Always consult with local healthcare providers familiar with Nepal's healthcare system and regulations.
Last Updated: October 19, 2026 |Clinic: Thamel Clinic |Licensed: Registered